Zhengyang Zhou1, Jian He1, Song Liu1, and Weibo Chen2
1Department of Radiology, Drum Tower Hospital, School of Medicine, Nanjing University, Nanjing, China, People's Republic of, 2Philips Healthcare Greater China, Shanghai, China, People's Republic of
Synopsis
Forty-five patients with gastric cancer underwent
DWI prior to surgery to evaluate whether ADC value correlates with the HER2 status.
HER2 status was compared among tumors with various histopathological features. Meanwhile,
the ADC values of gastric cancers with positive and negative HER2 were compared.
The mean ADC value of HER2-positive gastric cancers was significantly higher
than those of HER2-negative tumors. The minimal ADC value of HER2-positive
gastric cancers was significantly higher than those of HER2-negative tumors. The
ADC values of gastric cancer correlate with the HER2 status. DWI can predict
HER2 status and help in tailoring therapy for gastric cancer. Purpose: To evaluate
whether apparent diffusion coefficient (ADC) value of gastric cancer obtained
from diffusion weighted imaging (DWI) correlates with the HER2 status.
Methods: Forty-five
patients, who had been diagnosed with gastric cancer through biopsy, were
enrolled in this IRB-approved study. Each patient underwent a DWI (b values: 0
and 1,000 sec/mm2) prior to surgery (curative gastrectomy or palliative
resection). Postoperative microscopic findings, HER2 status by
immunohistochemical analysis and fluorescence in situ hybridization (FISH) were
obtained. HER2 status was compared among gastric cancers with various
histopathological features using the chi square test. The ADC values of gastric
cancers with positive and negative HER2 were compared using the student t test.
Results: A weak yet
significant correlation was observed between the mean ADC values and HER2
status (r = 0.312, P = 0.037) and scores (r = 0.419, P = 0.004). The mean ADC
value of HER2-positive gastric cancers was significantly higher than those of
HER2-negative tumors (1.211 vs. 0.984 mm2/s, P = 0.020). The minimal ADC value
of HER2-positive gastric cancers was significantly higher than those of
HER2-negative tumors (1.105 vs. 0.905 × 10−3 mm2/s, P = 0.036).
Conclusions: In this pilot
study, we have demonstrated that the ADC values of gastric cancer correlate
with the HER2 status. Future research is warranted to see if DWI can predict
HER2 status and help in tailoring therapy for gastric cancer.
Acknowledgements
No acknowledgement found.References
1.
Li W, Qin J, Sun YH, , et al. Neoadjuvant chemotherapy for advanced gastric cancer:
a meta-analysis. World J Gastroenterol. 2010;16:5621–8.
2.
Bang YJ, Van Cutsem E, Feyereislova A, et al. Trastuzumab in combination with
chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced
gastric or gastrooesophageal junction cancer (ToGA): a phase 3, open-label, randomized
controlled trial. Lancet. 2010;376:687–97.
3.
Fisher SB, Fisher KE, Squires MH, et al. HER2 in resected gastric cancer: is
there prognostic value? J Surg Oncol. 2014;109:61–6.
4.
Liu S, Guan W, Wang H, Pan L, Zhou Z, Yu H, et al. Apparent diffusion coefficient
value of gastric cancer by diffusion-weighted imaging: Correlations with the
histological differentiation and Lauren classification. Eur J Radiol.
2014;83:2122–8.
5.
Costantini M, Belli P, Distefano D, et al. Magnetic resonance imaging features
in triple-negative breast cancer: comparison with luminal and
HER2-overexpressing tumors. Clin Breast Cancer. 2012;12:331–9.